Keizo Ito
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in ⓘ
-
- Eicosanoids and Hypertension Pharmacology 8
-
- Neurological Disorders and Treatments 6
- Neurological Disease Mechanisms and Treatments 5
- Co-authors
- G. TSUKAMOTO (13 shared papers)Hiroshi Ohtaka (10 shared papers)Tsuneo KAWASHIMA (2 shared papers)Tomoya Kitazume (3 shared papers)Toshiro Kanazawa (9 shared papers)Takeshi Saito (6 shared papers)Masaaki Kurasaki (9 shared papers)Hideya Endo (1 shared paper)
- Journals
- Chemical and Pharmaceutical Bulletin (10 papers)Journal of Medicinal Chemistry (2 papers)The Japanese Journal of Pharmacology (15 papers)Scientific Reports (1 paper)Polar Biology (1 paper)
- Partner nations
- JapanUnited StatesSouth Africa
In The Last Decade
Keizo Ito
70 papers receiving 759 citations
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 58
- Pharmacology 64
- Organic Chemistry 199
- Biochemistry 41
- Pharmacology 102
Countries citing papers authored by Keizo Ito
This map shows the geographic impact of Keizo Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keizo Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keizo Ito more than expected).
Fields of papers citing papers by Keizo Ito
This network shows the impact of papers produced by Keizo Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keizo Ito. The network helps show where Keizo Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Keizo Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 100 | |
| 2 | 1986 | 86 | |
| 3 | 1980 | 65 | |
| 4 | 1990 | 49 | |
| 5 | 1994 | 39 | |
| 6 | 1988 | 33 | |
| 7 | 1986 | 32 | |
| 8 | 1992 | 29 | |
| 9 | 1990 | 29 | |
| 10 | 1986 | 26 | |
| 11 | 1993 | 23 | |
| 12 | 1989 | 22 | |
| 13 | 1987 | 20 | |
| 14 | 2001 | 14 | |
| 15 | 1997 | 14 | |
| 16 | 1982 | 14 | |
| 17 | The studies of the mechanism of antiinflammatory action of 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043). | 1982 | 14 |
| 18 | 1987 | 13 | |
| 19 | 1998 | 13 | |
| 20 | 1987 | 12 |
About Keizo Ito
Keizo Ito is a scholar working on Biochemistry, Neurology, Pharmacology, Biochemistry and Organic Chemistry, having authored 72 papers that have together received 821 indexed citations. Recurring topics across this work include Synthesis and biological activity (8 papers), Eicosanoids and Hypertension Pharmacology (8 papers), Neuroscience and Neuropharmacology Research (6 papers), Neurological Disorders and Treatments (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers), Receptor Mechanisms and Signaling (5 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). The work is most often cited by research in Clinical Biochemistry (58 citations), Pharmacology (64 citations), Organic Chemistry (199 citations), Biochemistry (41 citations) and Pharmacology (102 citations). Keizo Ito has collaborated with scholars based in Japan, United States and South Africa. Frequent co-authors include G. TSUKAMOTO, Hiroshi Ohtaka, Tsuneo KAWASHIMA, Tomoya Kitazume, Toshiro Kanazawa, Takeshi Saito, Masaaki Kurasaki, Hideya Endo, Tominori Morita and Takashi Nose. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Journal of Medicinal Chemistry, The Japanese Journal of Pharmacology, Scientific Reports and Polar Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.